RESEARCH TRIANGLE PARK – Sonablate, a Charlotte-based company focusing on minimally invasive focused ultrasound technologies, is looking to raise $60 million in capital.
Six investors have already signed on, committing $377,000, according to an SEC filing.
Sonoblate is a partner with the Mayo Clinic and received FDA approval for a device in 2017.
“[O]ur vision is to transform sound energy into focused healing. We aim to revolutionize the way physicians deliver healthcare to patients worldwide,” the company says at its website.
